Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,011 | -55,466 | -39,485 | -66,369 | -56,583 |
| Depreciation Amortization | 65,055 | 2,239 | 1,606 | 3,160 | 3,881 |
| Income taxes - deferred | -17,244 | -104 | 780 | -176 | N/A |
| Accounts receivable | 545 | -1,199 | -573 | -555 | -443 |
| Other Working Capital | 2,450 | -366 | 1,729 | 3,538 | -926 |
| Other Operating Activity | -9,055 | 8,002 | 8,842 | 46,550 | 33,144 |
| Operating Cash Flow | $-39,258 | $-46,895 | $-27,102 | $-13,853 | $-20,928 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,984 | -7,130 | N/A | N/A | N/A |
| PPE Investments | -3,186 | -3,657 | -2,692 | -531 | -575 |
| Net Acquisitions | N/A | 51 | N/A | 12,280 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -5,660 | -1,480 |
| Investing Cash Flow | $3,798 | $-10,737 | $-2,692 | $6,088 | $-2,055 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 133 | 1,827 | 1,041 | 667 | 150 |
| Debt Repayment | N/A | 11,763 | -202 | -197 | -3,150 |
| Common Stock Issued | 36,471 | 18,702 | 61,915 | 23,033 | 21,160 |
| Dividend Paid | N/A | N/A | N/A | -328 | N/A |
| Other Financing Activity | 0 | -1,621 | -565 | -14,434 | 1,909 |
| Financing Cash Flow | $36,604 | $30,672 | $62,190 | $8,742 | $20,069 |
| Exchange Rate Effect | N/A | N/A | N/A | 14 | 46 |
| Beginning Cash Position | 19,174 | 46,134 | 13,738 | 12,745 | 15,612 |
| End Cash Position | 20,318 | 19,174 | 46,134 | 13,738 | 12,745 |
| Net Cash Flow | $1,144 | $-26,960 | $32,396 | $992 | $-2,867 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,258 | -46,895 | -27,102 | -13,853 | -20,928 |
| Capital Expenditure | -3,186 | -3,657 | -2,692 | -531 | N/A |
| Free Cash Flow | -42,444 | -50,553 | -29,793 | -14,384 | -20,928 |